The Effect of Mankai on Glycemic Control Among Patients With T2D

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

August 8, 2024

Study Completion Date

August 15, 2024

Conditions

Diabetes Mellitus, Type 2

Interventions

DIETARY_SUPPLEMENT

Mankai supplementation

The overall dose of the three Mankai duckweed beverages/day contains \~10 grams of dry matter.

OTHER

Water consumption

Trial Locations (1)

Soroka Medical Center, Beersheba

All Listed Sponsors

collaborator

Soroka University Medical Center

OTHER

lead

Ben-Gurion University of the Negev

OTHER

NCT06416475 - The Effect of Mankai on Glycemic Control Among Patients With T2D | Biotech Hunter | Biotech Hunter